In preclinical melanoma models, beneficial bacteria such as Bifidobacterium have been shown to amplify the antitumor activity of oncolytic adenoviruses by increasing tumor infiltration of CD8+ T cells while depleting regulatory T cells (Tregs), which dampen immune responses [277, 278]. The gene discussed is CD8A; the disease is melanoma.